Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10,900 GBX | 0.00% | -0.46% | +19.52% |
Mar. 26 | Dr Martens cut to 'sell'; BofA likes Tullow | AN |
Mar. 25 | Judges Scientific Chair Hambro sells GBP110,000 in shares | AN |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company returns high margins, thereby supporting business profitability.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With an expected P/E ratio at 45.52 and 39.94 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Industrial Machinery & Equipment
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+19.52% | 900M | C- | ||
+9.08% | 82.5B | A- | ||
+19.53% | 70.16B | B | ||
+19.34% | 37.32B | B- | ||
+14.44% | 31.59B | A | ||
+7.43% | 28.13B | B- | ||
+3.40% | 26.77B | C+ | ||
+2.06% | 26.3B | B+ | ||
+14.45% | 24.99B | B+ | ||
+17.03% | 23.55B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- JDG Stock
- Ratings Judges Scientific plc